Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_03401 |
| Species: | Homo sapiens |
| Position : | chr10:43569045-43569456 |
| Year: | 2011 |
| Title: | Chromatin and DNA methylation dynamics during retinoic acid-induced RET gene transcriptional activation in neuroblastoma cells. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 20952403 |
| Cell Source: | SK-N-BE |
| Cell Type: | malignant cell |
| Cell Ontology ID: | CL:0001064 |
| Experiment Type: | Enhancer activity assay; TF-binding/chromatin assay |
| Low Throughput Method: | Luciferase reporter assay; Reporter assay; ChIP-qPCR/ChIP; RT-qPCR/qPCR |
| Target gene : | RET |
| TF name : | SOX10 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| SOX10 | Hs_Neural_Crest_Differentiation_WP2064_79263 | wikipathways | 40 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_03708 | chr10:43568986-43571244 | peripheral nervous system | neural crest derived neuroblast | Hirschsprung disease |
| E_03815 | chr10:43568986-43571244 | blood / hematopoietic system | NA | Hirschsprung Disease |
| E_03816 | chr10:43568986-43571244 | blood / hematopoietic system | NA | Hirschsprung Disease |
| E_03368 | chr10:43569015-43569494 | NA | neuroblastoma cell line | neuroblastoma |
| E_03400 | chr10:43569045-43569456 | NA | malignant cell | NA |
| E_03398 | chr10:43569296-43572684 | NA | malignant cell | NA |
| E_03399 | chr10:43569296-43572684 | NA | malignant cell | NA |